Altimmune, Inc. 10-Q filing
Filed 2025-11-06 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001326190-25-000064
- Form type
- 10-Q
- CIK
- 0001326190
- Primary document
- https://www.sec.gov/Archives/edgar/data/1326190/000132619025000064/alt-20250930x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Altimmune, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $15,000 | - | - |
| Operating Income | $-65.6M | - | - |
| Net Income | $-60.7M | - | - |
| Eps Basic | -0.74 | - | - |
| Eps Diluted | -0.74 | - | - |
| Cash And Equivalents | $61.2M | - | - |
| Total Assets | $218.4M | - | - |
| Total Liabilities | $32.8M | - | - |
| Shareholders Equity | $185.6M | - | - |
| Operating Cash Flow | $-48.1M | - | - |
| Capital Expenditures | $10,000 | - | - |